Catalog No.
RHC03205
Species reactivity
Human
Host species
Mouse
Isotype
IgG2b
Clonality
Monoclonal
Tested applications
WB: 1:500-1:2000
Target
Estrogen receptor, ER-alpha, ESR, ER, ESR1, Nuclear receptor subfamily 3 group A member 1, NR3A1, Estradiol receptor
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P03372
Applications
WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R2Y36
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)., PMID:40360544
MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatment., PMID:40287441
Novel Estrogen Receptor - Targeted Therapies in Hormone-Receptor Positive Breast Cancer., PMID:40163189
Upregulation of miR-99b-5p Modulates ESR1 Expression as an Adaptive Mechanism to Circumvent Drug Response via Facilitating ER/HER2 Crosstalk., PMID:40033677
Prediction of Response to Anti-HER2 Therapy Using A Multigene Assay., PMID:39826800
Integration of Immune Responses and Transcriptomic Signatures Reveals the Efficacy of Maternal Genetic Vaccination in a Pregnant Model and Its Neonates., PMID:39762199
A therapeutic algorithm guiding subsequent therapy selection after CDK4/6 inhibitors' failure: A review of current and investigational treatment for HR+/Her2- breast cancer., PMID:39433229
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer., PMID:39179659
Electrochemical aptasensor based on a dual signal amplification strategy of 1-AP-CNHs and ROP for highly sensitive detection of ERα., PMID:39128408
Investigating the therapeutic mechanism of Jiedu-Quyu-Ziyin Fang on systemic lupus erythematosus through the ERα-miRNA-TLR7 immune axis., PMID:38948043
Characterization of Potential Target Genes of Borneol in Increasing Trastuzumab Sensitivity in HER2+ Trastuzumab-Resistant Breast Cancer: Bioinformatics and In Vitro Studies., PMID:38809634
Bioinformatics and In Vitro Study Reveal ERα as The Potential Target Gene of Honokiol to Enhance Trastuzumab Sensitivity in HER2+ Trastuzumab-Resistant Breast Cancer Cells., PMID:38805864
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer., PMID:38513188
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma., PMID:38411438
Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer., PMID:38211404
Multiple-Pathway Synergy Alters Steroidogenesis and Spermatogenesis in Response to an Immunocastration Vaccine in Goat., PMID:38201210
Dulaglutide as a demethylating agent to improve the outcome of breast cancer., PMID:38174426
Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS)., PMID:38137385
Exploring the Spatial Landscape of the Estrogen Receptor Proximal Proteome With Antibody-Based Proximity Labeling., PMID:38122900
Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy., PMID:38103078
Estrogen receptor and programmed death ligand-1 expression in type 1 endometrial cancer and its associated clinicopathological characteristics., PMID:37797425
UPLC-Q-TOF-MS, network analysis, and molecular docking to investigate the effect and active ingredients of tea-seed oil against bacterial pathogens., PMID:37745048
Sequencing systemic therapy in hormone-receptor positive metastatic breast cancer: a modern paradigm., PMID:37574571
An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer., PMID:37279952
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer., PMID:37226020
Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators., PMID:36834918
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients., PMID:36826152
The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer., PMID:36769338
A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients., PMID:36478205
Effects of the synthetic progestin levonorgestrel on some aspects of thyroid physiology in common carp (Cyprinus carpio)., PMID:36244424
Sex differences in saliva-based DNA methylation changes and environmental stressor in young African American adults., PMID:36067197
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update., PMID:35759724
Pituitary luteinizing hormone synthesis starts in aromatase (cyp19a1b)-positive cells expressing esr1 and esr2b at the onset of puberty in Takifugu rubripes (fugu)., PMID:35552517
Periodontitis promotes the expression of gingival transmembrane serine protease 2 (TMPRSS2), a priming protease for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)., PMID:35472469
IL-27 promotes decidualization via the STAT3-ESR/PGR regulatory axis., PMID:35430461
Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay., PMID:35225653
Detection and Functional Analysis of Estrogen Receptor α Phosphorylated at Serine 216 in Mouse Neutrophils., PMID:35119660
Immunoprecipitation Analyses of Estrogen Receptor α Phosphorylated at Serine 216 in the Mouse Liver., PMID:35119658
Estrogen-Responsive Gene MAST4 Regulates Myeloma Bone Disease., PMID:35064934
Association Between Estrogen Receptors and GATA3 in Bladder Cancer: A Systematic Review and Meta-Analysis of Their Clinicopathological Significance., PMID:34690921
Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies., PMID:34623477
The Immunohistochemical Expression of MCM-3, -5, and -7 Proteins in the Uterine Fibroids., PMID:34449552
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer., PMID:33782032
MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma., PMID:33544437
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome., PMID:33268821
The Role of Autophagy-Mediated Dengue Virus Antibody-Dependent Enhancement Infection of THP-1 Cells., PMID:33202415
Management of Brain and Leptomeningeal Metastases from Breast Cancer., PMID:33198331
Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial., PMID:33109233
For research use only. Not for human or drug use.
